학술논문

Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Gastric Cancer Cohort
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 1 April 2024, 30(7):1264-1272)
Subject
Language
English
ISSN
15573265
10780432